Stem Cells Provide New Model for Lou Gehrig's Disease
Topic: Regenerative Medicine
Author: The Company of Biologists
Published: 2009/02/23
Contents: Summary - Introduction - Main Item - Related Topics
Synopsis: Researchers at the University of California Los Angeles developed an optimized protocol to generate motor neurons from human embryonic stem cells.
Introduction
Researchers at the University of California Los Angeles developed an optimized protocol to generate motor neurons from human embryonic stem cells (ES cells), which express normal or mutant forms of the SOD-1 gene, which is linked to inherited, familial ALS.Main Item
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a devastating condition in which motor neuron degeneration causes progressive loss of movement and muscle tone, leading to death.
Overcoming the limited success of previous models, a report published in Disease Models & Mechanisms (DMM), dmm.biologists.org describes how neurons can be derived from human stem cells, and engineered to mimic inherited ALS.
Researchers at the University of California Los Angeles developed an optimized protocol to generate motor neurons from human embryonic stem cells (ES cells), which express normal or mutant forms of the SOD-1 gene, which is linked to inherited, familial ALS. Resulting cells exhibit hallmark characteristics of motor nerve cells, and neurons expressing mutant SOD-1 display abnormalities typical of ALS. Defects included shortened cell projections and a reduced life span compared to cells containing the normal SOD-1 gene.
This human cell-derived model of ALS provides a new method of studying this disease and testing novel therapeutics. This is especially helpful as only one drug is approved to help slow ALS progression, and animal models currently used in drug development have had limited success. Additionally, this research may aid other gene-linked neurodegenerative diseases, as they too may benefit from studies in a human cell-derived model.
Disease Models & Mechanisms (DMM) is a new research journal publishing both primary scientific research, as well as review articles, editorials, and research highlights. The journal's mission is to provide a forum for clinicians and scientists to discuss basic science and clinical research related to human disease, disease detection and novel therapies. DMM is published by the Company of Biologists, a non-profit organization based in Cambridge, UK. The Company also publishes the international biology research journals Development, Journal of Cell Science, and The Journal of Experimental Biology. In addition to financing these journals, the Company provides grants to scientific societies and supports other activities including traveling fellowships for junior scientists, workshops and conferences. The world's poorest nations receive free and unrestricted access to the Company's journals.
Reference: The report was written by Saravanan Karumbayaram, Theresa K. Kelly, Andres A. Paucar, Anne J.T. Roe, Joy A. Umbach, Andrew Charles, Harley I. Kornblum, and Martina Wiedau-Pazos at the David Geffen School of Medicine at the University of California Los Angeles, and Steven A. Goldman at the University of Rochester Medical Center in Rochester, NY. The report is published in the March/April issue of Disease Models & Mechanisms (DMM), a research journal published by The Company of Biologists, a non-profit based in Cambridge, UK.
Explore Related Topics
1 - New Ethical Framework Introduced for Stem Cell-Based Embryo Research - A groundbreaking code of practice has been introduced for the use of stem cell-based embryo models in research.
2 - Making Stem Cells Behave Like Human Embryos - Human pluripotent stem cells in a lab can initiate a process resembling the gastrulation phase - where cells begin differentiating into new cell types - much earlier than occurs in mother nature.
3 - Organoids: Fitting a Mini Brain with a Tiny Cap - A tiny EEG electrode cap was created to measure activity in an organoid brain model the size of a pen dot to lead to a better understanding of neural disorders and how chemicals affect the brain.
4 - Mouse Embryo Created from Stem Cells: No Sperm, Egg, Uterus Needed - Solely from stem cells, without egg, sperm or womb, synthetic mouse embryo models were created.
5 - Progress on Stem Cell Therapy to Restore Sight - A multi-institutional effort is taking steps to develop an effective technique to regenerate photoreceptors cells and restore sight in people with vision disorders.
Page Information, Citing and Disclaimer
Disabled World is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.
Cite This Page (APA): The Company of Biologists. (2009, February 23). Stem Cells Provide New Model for Lou Gehrig's Disease. Disabled World. Retrieved October 7, 2024 from www.disabled-world.com/news/research/stemcells/stem-cells-lou-gehrigs-disease.php
Permalink: <a href="https://www.disabled-world.com/news/research/stemcells/stem-cells-lou-gehrigs-disease.php">Stem Cells Provide New Model for Lou Gehrig's Disease</a>: Researchers at the University of California Los Angeles developed an optimized protocol to generate motor neurons from human embryonic stem cells.
Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.